pan-KRAS-IN-16 is a pan-RAS small-molecule inhibitor derived from an intracellular antibody fragment, which inhibits RAS-effector protein-protein interactions by binding to a hydrophobic pocket near the RAS effector-binding switch region; it blocks endogenous RAS-dependent signaling in tumor cell lines.